PROEHL GERALD T - President, CEO and Chairman, Director, 10%+ Owner at Dermata Therapeutics, Inc.

Issuer-level insider activity

Role
President, CEO and Chairman, Director, 10%+ Owner
Issuer ticker
DRMA, DRMAW on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Company
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

No buys or sells have been reported by PROEHL GERALD T since 09 Sep 2025

Reported holdings for PROEHL GERALD T in Dermata Therapeutics, Inc.

Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Common Stock
Shares / value
292,631
Estimated value
$377,493
Report date
16 Aug 2026
Price
$1.29
Ownership
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Common Stock
Shares / value
79,795
Estimated value
$241,778
Report date
23 Dec 2025
Price
$3.03
Ownership
By Proehl Investment Ventures LLC
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Common Stock
Shares / value
7
Estimated value
$21
Report date
23 Dec 2025
Price
$3.03
Ownership
By Allison Taylor Proehl 2020 Irrevocable Trust
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Common Stock
Shares / value
3
Estimated value
$9
Report date
23 Dec 2025
Price
$3.03
Ownership
By Meghan Proehl Wilder 2020 Irrevocable Trust
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Pre-Funded Warrant (Right to Buy)
Shares / value
1,360,544
Estimated value
Report date
16 Aug 2026
Price
Ownership
By Proehl Investment Ventures LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Series E Warrant (Right to Buy)
Shares / value
1,360,544
Estimated value
Report date
16 Aug 2026
Price
Ownership
By Proehl Investment Ventures LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Series F Warrant (Right to Buy)
Shares / value
1,360,544
Estimated value
Report date
16 Aug 2026
Price
Ownership
By Proehl Investment Ventures LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Warrant (Right to Buy)
Shares / value
787,402
Estimated value
Report date
21 Jan 2025
Price
Ownership
By Proehl Investment Ventures LLC
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Series C Warrant (Right to Buy)
Shares / value
490,496
Estimated value
Report date
23 Dec 2025
Price
Ownership
By Proehl Family Trust
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Series D Warrant (Right to Buy)
Shares / value
490,496
Estimated value
Report date
23 Dec 2025
Price
Ownership
By Proehl Family Trust
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Series E Warrant (Right to Buy)
Shares / value
170,068
Estimated value
Report date
16 Aug 2026
Price
Ownership
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Series F Warrant (Right to Buy)
Shares / value
170,068
Estimated value
Report date
16 Aug 2026
Price
Ownership
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Series C Warrant (Right to Buy)
Shares / value
122,549
Estimated value
Report date
23 Dec 2025
Price
Ownership
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Series D Warrant (Right to Buy)
Shares / value
122,549
Estimated value
Report date
23 Dec 2025
Price
Ownership
By Sean Michael Proehl 2020 Irrevocable Trust Dated December 18, 2020
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Warrant (Right to Buy)
Shares / value
78,740
Estimated value
Report date
23 Dec 2025
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding President, CEO and Chairman, Director, 10%+ Owner

Dermata Therapeutics, Inc.

Security class
Stock Option (right to buy)
Shares / value
37,500
Estimated value
Report date
02 Jan 2026
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Transaction history for PROEHL GERALD T in Dermata Therapeutics, Inc.

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .